127 related articles for article (PubMed ID: 36583461)
1. A unique presentation of T-lymphoblastic lymphoma in a pediatric patient with a germline RUNX1 mutation.
Gartstein E; Orr K; Eames G; Firan M; Howrey R; Ray A
Pediatr Blood Cancer; 2023 May; 70(5):e30184. PubMed ID: 36583461
[No Abstract] [Full Text] [Related]
2. Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.
Aljamaan K; Aljumah TK; Aloraibi S; Absar M; Iqbal Z
Asian Pac J Cancer Prev; 2015; 16(17):7523-7. PubMed ID: 26625756
[TBL] [Abstract][Full Text] [Related]
3. Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia.
Prebet T; Carbuccia N; Raslova H; Favier R; Rey J; Arnoulet C; Vey N; Vainchenker W; Birnbaum D; Mozziconacci MJ
Eur J Haematol; 2013 Sep; 91(3):277-279. PubMed ID: 23692290
[No Abstract] [Full Text] [Related]
4. IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate
Ågerstam H; Lilljebjörn H; Rissler M; Sandén C; Fioretos T
Haematologica; 2023 Feb; 108(2):599-604. PubMed ID: 36226493
[No Abstract] [Full Text] [Related]
5. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.
Barbosa TC; Oliveira E; Blunck CB; Maciel A; Bastos A; Bouzada H; Rouxinol ST; Mansur MB; Costa ES; Almeida CW; Emerenciano M
Cancer Genet; 2023 Aug; 276-277():40-42. PubMed ID: 37480760
[No Abstract] [Full Text] [Related]
6. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
[TBL] [Abstract][Full Text] [Related]
7. To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.
Avagyan S; Brown AL
J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623329
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
[TBL] [Abstract][Full Text] [Related]
9. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
10. Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
Yu W; Wang W; Yu X
PLoS One; 2021; 16(6):e0253012. PubMed ID: 34101758
[TBL] [Abstract][Full Text] [Related]
11. A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia.
Abdelhaleem M; Yi Q; Beimnet K; Hitzler J
Leukemia; 2006 Jul; 20(7):1294. PubMed ID: 16673018
[No Abstract] [Full Text] [Related]
12. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
[No Abstract] [Full Text] [Related]
13. Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.
Grossmann V; Kern W; Harbich S; Alpermann T; Jeromin S; Schnittger S; Haferlach C; Haferlach T; Kohlmann A
Haematologica; 2011 Dec; 96(12):1874-7. PubMed ID: 21828118
[TBL] [Abstract][Full Text] [Related]
14. Impact of pinworm infection on the development of murine B-cell leukemia/lymphoma in the presence and absence of
Fitch BA; Situ J; Wiemels JL; Kogan SC; Zhou M
Haematologica; 2023 Dec; 108(12):3480-3484. PubMed ID: 37345483
[No Abstract] [Full Text] [Related]
15. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
[TBL] [Abstract][Full Text] [Related]
16. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
[TBL] [Abstract][Full Text] [Related]
17. Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases.
Reichard KK; Kang H; Robinett S
Mod Pathol; 2011 Dec; 24(12):1606-11. PubMed ID: 21822204
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
Amare Kadam PS; Raje GC; Pais AP; Banavali S
Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
[TBL] [Abstract][Full Text] [Related]
19. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
[TBL] [Abstract][Full Text] [Related]
20. Five percent of healthy newborns have an
Schäfer D; Olsen M; Lähnemann D; Stanulla M; Slany R; Schmiegelow K; Borkhardt A; Fischer U
Blood; 2018 Feb; 131(7):821-826. PubMed ID: 29311095
[No Abstract] [Full Text] [Related]
[Next] [New Search]